Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
122107362 | 12210736 | 2 | F | 20151118 | 20160325 | 20160706 | PER | US-MALLINCKRODT-T201505343 | MALLINCKRODT | 0.00 | M | Y | 0.00000 | 20160706 | CN | US | US |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
122107362 | 12210736 | 1 | PS | METHADOSE | METHADONE HYDROCHLORIDE | 1 | Unknown | UNK | U | UNKNOWN | 17116 | ||||||||
122107362 | 12210736 | 2 | SS | ROXICODONE | OXYCODONE HYDROCHLORIDE | 1 | Unknown | UNK | U | UNKNOWN | 0 | TABLET | |||||||
122107362 | 12210736 | 3 | SS | LYRICA | PREGABALIN | 1 | 0 | ||||||||||||
122107362 | 12210736 | 4 | SS | GABAPENTIN. | GABAPENTIN | 1 | 0 | ||||||||||||
122107362 | 12210736 | 5 | SS | IBUPROFEN. | IBUPROFEN | 1 | 0 | ||||||||||||
122107362 | 12210736 | 6 | SS | TRAZODONE | TRAZODONE HYDROCHLORIDE | 1 | 0 | ||||||||||||
122107362 | 12210736 | 7 | SS | DIAZEPAM. | DIAZEPAM | 1 | 0 | ||||||||||||
122107362 | 12210736 | 8 | SS | TYLENOL EXTRA STRENGTH | ACETAMINOPHEN | 1 | 0 | ||||||||||||
122107362 | 12210736 | 9 | SS | ACETYLSALICYLIC ACID | ASPIRIN | 1 | 0 | ||||||||||||
122107362 | 12210736 | 10 | SS | DOCUSATE SODIUM. | DOCUSATE SODIUM | 1 | 0 | ||||||||||||
122107362 | 12210736 | 11 | SS | SENNA-S | DOCUSATE SODIUMSENNOSIDES | 1 | 0 |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
122107362 | 12210736 | 1 | Product used for unknown indication |
122107362 | 12210736 | 2 | Product used for unknown indication |
122107362 | 12210736 | 3 | Product used for unknown indication |
122107362 | 12210736 | 4 | Product used for unknown indication |
122107362 | 12210736 | 5 | Product used for unknown indication |
122107362 | 12210736 | 6 | Product used for unknown indication |
122107362 | 12210736 | 7 | Product used for unknown indication |
122107362 | 12210736 | 8 | Product used for unknown indication |
122107362 | 12210736 | 9 | Product used for unknown indication |
122107362 | 12210736 | 10 | Product used for unknown indication |
122107362 | 12210736 | 11 | Product used for unknown indication |
Outcome of event
no results found |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
122107362 | 12210736 | Abasia | |
122107362 | 12210736 | Chest pain | |
122107362 | 12210736 | Constipation | |
122107362 | 12210736 | Drug effect decreased | |
122107362 | 12210736 | Headache | |
122107362 | 12210736 | Hypertension | |
122107362 | 12210736 | Insomnia | |
122107362 | 12210736 | Nausea | |
122107362 | 12210736 | Vomiting | |
122107362 | 12210736 | Weight decreased |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
no results found |